4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0001209191-23-040338
Options or other derivatives
- President and CFO acquired 19,787,969 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Alspaugh Jonathan President and CFO | 2023-06-22 | Grant or award · Employee Stock Option (right to buy) | +19,787,969 | 19,787,969 | D: show line 1 in the form |
Loading xslF345X04/doc4.xml…